Galera Therapeutics Announces Presentation of Avasopasem Manganese (GC4419) Two-Year Tumor Outcomes Data at 2020 Multidisciplinary Head and Neck Cancers Symposium

NEXT STORY
Ziopharm Oncology to Host Conference Call to Discuss Fourth Quarter and Full Year 2019 Results on March 2, 2020
PREV STORY
Enochian Biosciences Announces FDA INTERACT Meeting for a Potential Cure for HIV
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Targovax submits a study of its adenovirus based immune therapy ONCOS-102 to the regulatory authorities in Spain

OSLO, Norway, Feb. 2, 2016 (GLOBE NEWSWIRE) -- Targovax has submitted a study protocol ...

author_avatar
NASDAQ Market News

Sanofi and Alnylam Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy

Sanofi and Alnylam Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran ...

author_avatar
NASDAQ Market News

TMCIGlobal Offers AAFP CME Credit for Medical Cannabis Curriculum

-- Curriculum for healthcare providers now offers 13 AAFP Elective credits -- CHARLOTTESVILLE, Va., ...

author_avatar
NASDAQ Market News